BDRX
Biodexa Pharmaceuticals plc American Depositary Shs
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
BDRX Stock Analysis: Buy, Sell, or Hold?
$2.37
-0.03 (-1.46%)
âŧ
5d:
-1.87%
30d:
+387.73%
90d:
+55.59%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (42%)
Quality Score
32/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$0.34 â $3.03
Position: SLIGHTLY HIGH
Wall Street Target
$71.88
+2894.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.28 / $4.07
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: BDRX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When BDRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BDRX is currently trading at $2.37, which is considered slightly high relative to its 30-day fair value range of $0.34 to $3.03.
Technical Outlook: Technically, BDRX is in a downtrend. Immediate support is located at $2.28, while resistance sits at $4.07.
Market Sentiment: BDRX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $71.88 (+2894.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDRX is in a downtrend. Immediate support is located at $2.28, while resistance sits at $4.07.
Market Sentiment: BDRX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $71.88 (+2894.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.34 -
$3.03
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.1%
Trading Range & Key Levels
30-Day Trading Range
$0.34 -
$3.03
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$2.28
Resistance Level
$4.07
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 2894.8% below Wall St target ($71.88)
- WARNING: Composite score 32/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Wall Street Target
$71.88
(+2894.8%)
Revenue Growth (YoY)
-64.1%
Share BDRX Analysis
Share this live BDRX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 12, 2026 1:21 PM ET
Data refreshes hourly during market hours. Next update: 2:21 PM
Data refreshes hourly during market hours. Next update: 2:21 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 65 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$689 | 58 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 46 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BDRX Research Pages
